Trial intelligence / Profile preview

Peramivir sodium chloride injection in pediatric influenza

CTR20150825Phase 4Active

Sponsor
Guangzhou Nanxin Pharmaceutical
Start
Feb 2016
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

A Phase 4 trial of peramivir in influenza, sponsored by Guangzhou Nanxin Pharmaceutical. Started Feb 2016; status: active.

02

Drugs

peramivir
03

Conditions

influenza

Beyond the preview

Go deeper on CTR20150825.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20150825.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call